The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•13 April 2026•

1 min read

IDEXX Laboratories Shares Slip Despite Strong Fundamentals and Insider Selling

A man in a suit over a stock chart with 'Mondelez International' text, surrounded by chocolate, cocoa beans, factories, and shops.

Key Facts

1IDEXX Laboratories stock dropped 3.7% to reach $563.00.

2The company achieved a GF Score of 99/100, indicating excellent profitability and growth.

IDEXX Laboratories (IDXX) shares experienced a 3.7% decline, closing at $563.00 and entering "modestly undervalued" territory according to valuation metrics. Despite the recent price drop, the company maintains an exceptional GF Score of 99/100, signaling robust profitability and long-term growth potential. Current market data suggests the stock is trading approximately 9.8% below its estimated intrinsic value of $623.96. However, investor sentiment is being tested by significant insider selling totaling $29.9 million recorded recently. With the stock down 16.8% year-to-date, the market faces a mixed outlook that balances strong fundamental metrics against negative price momentum and insider exits.